![]() |
Volumn 24, Issue 11, 2012, Pages
|
Transient Receptor Potential Vanilloid 4 blockade protects against experimental colitis in mice: A new strategy for inflammatory bowel diseases treatment?
|
Author keywords
2,4,6 trinitrobenzenesulfonic acid induced colitis; Animal models of gastrointestinal inflammation; Colorectal pain; Inflammatory bowel disease; RN 1734; Transient Receptor Potential Vanilloid 4
|
Indexed keywords
MESSENGER RNA;
MYELOPEROXIDASE;
RN 1734;
RUTHENIUM RED;
TRINITROBENZENESULFONIC ACID;
UNCLASSIFIED DRUG;
VANILLOID RECEPTOR 4;
VANILLOID RECEPTOR ANTAGONIST;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
COLITIS;
CONTROLLED STUDY;
DOSAGE SCHEDULE COMPARISON;
DRUG ADMINISTRATION ROUTE;
DRUG EFFECT;
ENTERITIS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
INTRACOLONIC DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RECEPTOR BLOCKING;
TREATMENT OUTCOME;
UPREGULATION;
ANIMALS;
DISEASE MODELS, ANIMAL;
GASTROINTESTINAL AGENTS;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
MICE;
PAIN;
REAL-TIME POLYMERASE CHAIN REACTION;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SULFONAMIDES;
TRPV CATION CHANNELS;
|
EID: 84867510058
PISSN: 13501925
EISSN: 13652982
Source Type: Journal
DOI: 10.1111/j.1365-2982.2012.01999.x Document Type: Article |
Times cited : (73)
|
References (8)
|